alexa A Possible New Approach For Malaria Treatment Combining Selective Nutrition And Resistance?proof Antimalarial Drugs
ISSN: 2155-9864

Journal of Blood Disorders & Transfusion
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Conference on Hematology & Blood Disorders
September 29-October 01, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Knox Van Dyke
Keynote: J Blood Disorders Transf
DOI: 10.4172/2155-9864.S1.005
Abstract
Malarial treatment for young children and pregnant women has been mostly ineffective since deaths of millions occur yearly. Many of these deaths occur in Africa owing to a combination of ineffective treatment and either malnutrition or ineffective nutrition. The key question is what makes young children and pregnant mothers vulnerable to malaria? An important component in the human body which is responsible for keeping malaria under control is the activated macrophage. Activated macrophages have a nitric oxide synthase which is inducible (NOS-2). NOS-2 can make large quantities of nitric oxide in a continuous way which after reacting with forms of oxygen produces chemistry eg. peroxynitrite (OONO.) which can kill parasite. The substrates for NO synthase are L-arginine and oxygen and the products are nitric oxide (NO.) and also L-citrulline which can be recycled back to arginine to react again. A marked deficiency of L-arginine exists in young children with cerebral malaria. Parasites release l-arginase which depletes L-arginine. Malarial patients also release assymetrical dimethyl arginine which inhibits NO synthase. L-arginine is essential to children and its deficiency leaves them vulnerable to disease. (L-arginine and L-citrulline) given continuously, resolves the deficiency of NO production. A further treatment of chloroquine/ bisbenzylisoquinoline or artemisinin/bisbenzylisoquinoline above as outlined in Hematology 2013 should resolve this major problem in malaria.
Biography
Knox Van Dyke completed his PhD in Biochemistry in the Edward A Doisy?Nobel Prize Department at Saint Louis University in 1966. He did Postdoctoral studies in the Department of Pharmacology at West Virginia University. During this time he developed the first effective drug screening system for antimalarial drugs while screening over 10,000 drugs. Mefloquine and halofantrine were recognized by this screening system and were further developed by Walter Reed and various companies as patented drugs. He has over 300 publications and 150 patents.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords